INDOAMIN

Indo Amines Limited

Indo Amines Limited (INDOAMIN) financial statements and selected valuation metrics through 30 June 2026.

Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals

indoaminesltd.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹143.86
Market cap
1,044 Cr
Stock P/E
12.9
P/B
2.66
Dividend yield
0.3%
ROE (FY26)
20.1%
ROCE (FY26)
18.4%
Operating margin (FY26)
8.7%
Debt / equity (FY26)
0.79
OCF / EBITDA (FY26)
64.2%
OCF / EBITDA (3Y)
78.9%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Indo Amines manufactures specialty chemicals, including morpholine and derivatives, and sells them in domestic and international markets.

Company snapshot

43rdBy market cap

Ranked among 68 companies in Specialty Chemicals.

What we see

Positives
  • ✓Return on equity of 20.1% — the company generates strong returns on shareholders' money.

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales253 Cr194 Cr253 Cr265 Cr269 Cr259 Cr285 Cr288 Cr277 Cr277 Cr318 Cr375 Cr
Operating expenses (approx.)233 Cr174 Cr236 Cr237 Cr245 Cr234 Cr261 Cr256 Cr245 Cr252 Cr283 Cr322 Cr
EBITDA20 Cr20 Cr17 Cr28 Cr24 Cr24 Cr25 Cr31 Cr32 Cr25 Cr34 Cr53 Cr
OPM %8.0%10.3%6.9%10.4%8.9%9.4%8.7%10.9%11.5%9.1%10.8%14.1%
Other income5 Cr2 Cr5 Cr8 Cr5 Cr2 Cr0.28 Cr16 Cr5 Cr2 Cr6 Cr1 Cr
Interest6 Cr6 Cr5 Cr5 Cr6 Cr6 Cr6 Cr6 Cr6 Cr6 Cr6 Cr6 Cr
Depreciation3 Cr4 Cr4 Cr4 Cr4 Cr4 Cr4 Cr5 Cr5 Cr5 Cr6 Cr6 Cr
Profit before tax16 Cr12 Cr13 Cr26 Cr19 Cr17 Cr15 Cr36 Cr26 Cr16 Cr29 Cr42 Cr
Tax %27.7%22.9%27.2%24.7%29.0%32.6%22.3%18.9%29.2%27.1%28.5%26.2%
Net profit12 Cr10 Cr9 Cr19 Cr14 Cr11 Cr12 Cr29 Cr18 Cr12 Cr21 Cr31 Cr
EPS (₹)₹1.75₹1.30₹1.32₹2.70₹1.96₹1.52₹1.68₹3.94₹2.50₹1.62₹2.73₹4.19

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales302 Cr359 Cr489 Cr479 Cr541 Cr786 Cr945 Cr944 Cr1,079 Cr1,160 CrSign in free for the trailing twelve months
Operating expenses (approx.)266 Cr318 Cr435 Cr437 Cr479 Cr734 Cr858 Cr864 Cr978 Cr1,037 CrSign in free for the trailing twelve months
EBITDA36 Cr41 Cr54 Cr42 Cr61 Cr52 Cr87 Cr79 Cr101 Cr123 CrSign in free for the trailing twelve months
OPM %11.9%11.4%11.0%8.8%11.3%6.6%9.2%8.4%9.4%10.6%Sign in free for the trailing twelve months
Other income3 Cr1 Cr7 Cr7 Cr8 Cr10 Cr4 Cr16 Cr15 Cr29 CrSign in free for the trailing twelve months
Interest4 Cr5 Cr9 Cr11 Cr9 Cr14 Cr17 Cr22 Cr22 Cr24 CrSign in free for the trailing twelve months
Depreciation12 Cr12 Cr14 Cr20 Cr11 Cr14 Cr17 Cr15 Cr17 Cr21 CrSign in free for the trailing twelve months
Profit before tax23 Cr25 Cr38 Cr18 Cr49 Cr35 Cr57 Cr58 Cr77 Cr106 CrSign in free for the trailing twelve months
Tax %29.0%36.1%34.5%30.1%23.4%33.2%28.0%26.3%27.4%25.2%Sign in free for the trailing twelve months
Net profit16 Cr16 Cr25 Cr13 Cr38 Cr23 Cr41 Cr43 Cr56 Cr79 CrSign in free for the trailing twelve months
EPS (₹)₹4.90₹4.67₹7.40₹3.43₹10.69₹3.26₹5.78₹6.06₹7.70₹10.79Sign in free for the trailing twelve months
Dividend payout %————-14.1%-9.2%8.6%8.3%6.3%4.6%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital33 Cr33 Cr33 Cr35 Cr35 Cr35 Cr35 Cr35 Cr36 Cr36 Cr
Reserves36 Cr48 Cr69 Cr100 Cr127 Cr153 Cr190 Cr228 Cr281 Cr356 Cr
Borrowings56 Cr82 Cr116 Cr129 Cr148 Cr207 Cr232 Cr217 Cr284 Cr311 Cr
Other liabilities87 Cr122 Cr101 Cr98 Cr143 Cr159 Cr139 Cr153 Cr177 Cr193 Cr
Total liabilities213 Cr285 Cr320 Cr362 Cr453 Cr554 Cr597 Cr633 Cr779 Cr897 Cr
Fixed assets (net)53 Cr58 Cr83 Cr92 Cr105 Cr167 Cr187 Cr193 Cr251 Cr312 Cr
CWIP2 Cr5 Cr8 Cr24 Cr54 Cr22 Cr21 Cr23 Cr35 Cr31 Cr
Investments0.09 Cr0.09 Cr0.09 Cr0.09 Cr0.09 Cr0.09 Cr0.36 Cr2 Cr3 Cr3 Cr
Loans & advances——3 Cr1 Cr0.88 Cr0.14 Cr0.22 Cr0.22 Cr0.38 Cr0.26 Cr
Inventories33 Cr52 Cr63 Cr82 Cr88 Cr123 Cr136 Cr114 Cr140 Cr178 Cr
Trade receivables61 Cr72 Cr111 Cr96 Cr131 Cr167 Cr187 Cr217 Cr266 Cr282 Cr
Cash & bank5 Cr8 Cr9 Cr10 Cr15 Cr24 Cr6 Cr4 Cr3 Cr7 Cr
Other assets58 Cr89 Cr42 Cr57 Cr58 Cr51 Cr60 Cr81 Cr81 Cr85 Cr
Total assets213 Cr285 Cr320 Cr362 Cr453 Cr554 Cr597 Cr633 Cr779 Cr897 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity15 Cr5 Cr22 Cr39 Cr56 Cr35 Cr20 Cr70 Cr91 Cr79 Cr
Cash from investing-23 Cr-21 Cr-44 Cr-36 Cr-50 Cr-33 Cr-30 Cr-27 Cr-89 Cr-71 Cr
Cash from financing7 Cr19 Cr23 Cr-3 Cr-1 Cr7 Cr4 Cr-41 Cr-7 Cr-1 Cr
Net cash flow-1 Cr3 Cr2 Cr0.03 Cr5 Cr9 Cr-5 Cr2 Cr-5 Cr7 Cr
Free cash flow (OCF − Capex)-3 Cr-17 Cr-21 Cr2 Cr6 Cr-5 Cr-11 Cr39 Cr-0.47 Cr0.36 Cr

Ratios

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %21.3%18.4%21.5%11.1%18.8%12.3%16.2%16.7%16.5%18.4%
ROE %23.4%19.8%24.2%9.5%23.1%12.3%18.1%16.2%17.6%20.1%
Debtor days74738373887772849088
Inventory days658067107958278657084
Days payable799484881138460676463
Cash conversion cycle605966927175918296109
OCF / EBITDA %40.6%11.9%41.1%92.0%91.6%67.4%23.4%87.7%90.0%64.2%
OCF / EBITDA % (3 years)——31.8%48.0%74.4%83.6%55.7%57.2%67.6%78.9%
Debt / equity0.821.011.130.960.911.101.030.820.900.79
Current ratio——1.081.121.121.081.211.301.261.30
Net debt / EBITDA1.441.811.982.832.173.522.592.682.792.48